Phase Ib Study of Immunocytokine Simlukafusp Alfa (FAP-IL2v) Combined with Pembrolizumab for Treatment of Advanced and/or Metastatic Melanoma
免疫细胞因子 Simlukafusp Alfa (FAP-IL2v) 联合 Pembrolizumab 治疗晚期和/或转移性黑色素瘤的 Ib 期研究
期刊:Cancer Research Communications
影响因子:2
doi:10.1158/2767-9764.CRC-24-0601
Eva Munoz-Couselo, Ainara Soria Rivas, Shahneen Sandhu, Georgina V Long, Miguel F Sanmamed, Anna Spreafico, Elizabeth Buchbinder, Mario Sznol, Hans Prenen, Alexander Fedenko, Mohammed Milhem, Ana Maria Arance Fernandez, Jean-Jacques Grob, Lev Demidov, Caroline Robert, Christin Habigt, Stefan Evers,
免疫
黑色素瘤
其它细胞
FlowCytometry
Human
HLA-DRA